Skip to main content

Advertisement

SpringerLink
Log in

Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities

  • Review
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

Intraperitoneal carcinomatosis accounts for 25–35% of recurrences of colorectal cancer. Studies demonstrate that peritoneal carcinomatosis is not necessarily a terminal condition with no options for treatment or cure.

Results

The combination of aggressive cytoreductive surgery and intra-abdominal hyperthermia chemotherapy improves long-term overall survival in selected patients but is a time-consuming procedure (approx. 12 h) and entails high mortality (5%) and morbidity (35%)). Most commonly used drugs are mitomycin C and platinum compounds, which have synergistic toxic effects on tumor cells when hyperthermia is applied.

Conclusion

Since combined treatment seems promising only in peritoneal carcinomatosis stages I and II, the precondition for a reasonable combined treatment is careful staging. The mode of chemotherapy, the kind of drugs used for chemoperfusion, the timing of surgery, and the role of additional systemic chemotherapy must be evaluated in randomized studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Becker HD, Hohenberger W, Junginger T, Schlag PM (2002) Chirurgische Onkologie. Thieme, Stuttgart, pp 399–436

  2. Chu DZ, Lang NP, Thompson C, et al (1989) Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63:364–367

    CAS  PubMed  Google Scholar 

  3. Brodsky JT, Cohen AM (1991) Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 34:723–727

    CAS  PubMed  Google Scholar 

  4. Sugarbaker PH (1994) Intraperitoneal chemotherapy and cytoreductive surgery for prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 37:115–122

    PubMed  Google Scholar 

  5. Zoetmulder FAN (1996) Cancer cell seeding during abdominal surgery. Experimental studies. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer, Boston, pp 155–161

  6. Shepherd NA, Baxter KJ, Love SB (1997) The prognostic importance of peritoneal involement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102

    CAS  PubMed  Google Scholar 

  7. Hase K, Ueno H, Kuranga N, et al (1998) Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 41:1134–1140

    CAS  PubMed  Google Scholar 

  8. Solomon MJ, Egan M, Roberts RA, et al (1997) Incidence of free colorectal cancer cells on the peritoneal surface. Dis Colon Rectum 40:1294–1298

    CAS  PubMed  Google Scholar 

  9. Vogel P, Rüschoff J, Kümmel S, et al (2000) Prognostic value of microscopic peritoneal dissemination. Dis Colon Rectum 1:92–100

    Google Scholar 

  10. Schott A, Vogel I, Krueger U, et al (1998) Isolated tumor cells are frequently detectable in peritoneal cavity of gastric and colorectal cancer patients and serve as new prognostic marker. Ann Surg 227:327–379

    Article  Google Scholar 

  11. Minsky BD, Mies C, Rich TA, et al (1988) Potential curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 6:106–118

    CAS  PubMed  Google Scholar 

  12. Dawson LE, Russell AH, Tong D, et al (1983) Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 32:95–99

    Google Scholar 

  13. Sadeghi B, Arvieux C, Glehen O, et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies. Cancer 88:358–363

    Article  CAS  PubMed  Google Scholar 

  14. Ketcham AS, Hoye RC, Pilch YH, Morton DL (1970) Delayed intestinal obstruction following treatment for cancer. Cancer 25:406–410

    CAS  PubMed  Google Scholar 

  15. McCarthy JD (1986) A strategy for intestinal obstruction of peritoneal carcinomatosis. Arch Surg 21:1081–1082

    Google Scholar 

  16. Weill FS, Costats R, Guetarini S, Maltoni I, Rohmer P (1990) Diagnostic echographiques des metastases peritoneales ches les maladies ascitiques. J Radiol 71:365–368

    CAS  PubMed  Google Scholar 

  17. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636

    CAS  PubMed  Google Scholar 

  18. Gilly FN, Carry PY, Sayag AC (1994) Regional chemotherapy with mitomycin C and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124–129

    CAS  PubMed  Google Scholar 

  19. Pestieau SR, Sugerbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis. Dis Colon Rectum 43:1341–1348

    CAS  PubMed  Google Scholar 

  20. Saltz LB, Cox JV, Blanke C, et al (2000) Irinotecan plus fluorouracil for metastatic colorectal cancer. N Engl J Med 343:905–914

    Google Scholar 

  21. Gunderson LL, Sosin H, Levitt S (1985) Extrapelvic colon areas of failure in a reoperation serious: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 11:731–741

    CAS  PubMed  Google Scholar 

  22. Weisberger AS, Levine B, Storaasli JP (1955) Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA 159:1704–1707

    Google Scholar 

  23. Elias D, Bonnay M, Puizillou JM, et al (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmocokinetics and tissue distribution. Ann Oncol 13:267–272

    Article  CAS  PubMed  Google Scholar 

  24. Scheithauer W, Kornek GV, Marczell A, et al (1998) Combined intravenous and intraperitoneal chemotherapy with fluoruracil+leucovorin vs fluoruracil+levamisol for adjuvant therapy of resected colon carcinoma. Br J Cancer 77:1349–1354

    CAS  PubMed  Google Scholar 

  25. Vaillant JC, Nordlinger B, Deuffic S, et al (2000) Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer. Ann Surg 231:449–456

    Article  CAS  PubMed  Google Scholar 

  26. Graf W, Westlin JE, Pahlman L, Glimelius B (1994) Adjuvant intraperitoneal 5-fluoruracil and intravenous leucovorin after colorectal cancer surgery: a randomised phase II placebo-controlled study. Int J Colorectal Dis 9:35–39

    CAS  PubMed  Google Scholar 

  27. Elias D, Blot F, El Otmany A, et al (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–76

    Article  CAS  PubMed  Google Scholar 

  28. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC (1981) Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumors. Cancer Res 41:1096–1099

    CAS  PubMed  Google Scholar 

  29. Hahn GM, Shiu EC (1983) Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res 43:5789–5791

    CAS  PubMed  Google Scholar 

  30. Armour EP, McEachern D, Wang Z, Corry PM, Martinez A (1993) Sensitivity of human cells to mild hyperthermia. Cancer Res 53:2740–2744

    CAS  PubMed  Google Scholar 

  31. Reed RA Bedford JS (1980) Thermal tolerance. Br J Radiol 53:920–921

    PubMed  Google Scholar 

  32. Ozols RF, Locker GY, Doroshov JH (1979) Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39:3209–3214

    CAS  PubMed  Google Scholar 

  33. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42

    CAS  PubMed  Google Scholar 

  34. Gilly FN, Carry PY, Sayag AC (1992) Intraperitoneal chemohyperthermia with mitomycin C in dogs: general biological and anastomotic tolerance. Int J Hyperthermia 8:659–666

    CAS  PubMed  Google Scholar 

  35. Sugarbaker PH, Gianola FJ, Spreyer JL, et al (1985) Prospective randomised trail of intravenous versus intraperitoneal 5-fluoruracil in patients with advanced primary colon or rectal cancer. Surgery 98:414–421

    CAS  PubMed  Google Scholar 

  36. Beaujard A, Glehen O, et al (2000) Intraperitoneal chemohyperthermia with Mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2513–2519

    Article  Google Scholar 

  37. Kzu M, Koksoy C, Kale T, Demirpence E, Renda N (1998) Experimental study of the effect of preoperative 5-fluorouracil on integrity of colon anastomoses. Br J Surg 85:236–239

    Article  PubMed  Google Scholar 

  38. Shimizu T, Maeta M, Koga S (1991) Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Br J Surg 78:57–59

    CAS  PubMed  Google Scholar 

  39. Sugerbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132

    CAS  PubMed  Google Scholar 

  40. Yonemura Y, Ninomya I, Sugiyama K, et al (1995) Prophylaxis with intraoperative chemo-hyperthermia against peritoneal recurrence of serosal invasion-positive cancer. World J Surg 19:450–455

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054, Erlangen, Germany

    C. Knorr, B. Reingruber, T. Meyer, W. Hohenberger & C. Stremmel

Authors
  1. C. Knorr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Reingruber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Hohenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Stremmel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Stremmel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knorr, C., Reingruber, B., Meyer, T. et al. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Int J Colorectal Dis 19, 181–187 (2004). https://doi.org/10.1007/s00384-003-0524-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-003-0524-x

Keywords

Search

Navigation